Role of Meditation and Homoeopathy in Helping People Reduce or Quit Tobacco Use

INTERVENTION: Intervention1: Group I: Homeopathic Medicine Cytisus Laburnum (CL) + RYM: Cystisus 6C 4 pills/ thrice daily for 15 days, followed by Cystisus 30C, 4 pills / thrice daily for 15 days, followed by Cystisus 200C, 4pills /every weekday for 30 days, followed by Cystisus 1M, 4pills /once fortnightly 30 days. Intervention may be continued for 3 more months if required, as per Homeopathy Principles Intervention2: Group 2: Individualized homoeopathy (IH) + RYM: IH 6C 4pills/thrice daily for 15 days. followed by IH 30C, 4pills/thrice daily for 15 days, followed by IH 200C, 4 pills /every weekday for 30 days, followed by IH 1M, 4pills /once fortnightly for 30 days Control Intervention1: Group 3: Placebo (PL) + RYM: PL 6C: 4pills/thrice daily for 15 days. followed by PL 30C 4pills/thrice daily for 15 days, followed by PL 200C one 4 pills /every weekday for 30 days followed by PL 1M one dose of 4pills /once fortnightly for 30 days || CONDITION: Health Condition 1: F172‐ Nicotine dependence PRIMARY OUTCOME: Primary Feasibility Outcomes ; Recruitment rate per month. ; Retention of participants throughout the trial. ; Adherence to study medication and Raj yoga sessions. ; Blinding integrity. ; Completeness of outcome data.Timepoint: Baseline, Day 2, Weekly from 1 to 12 weeks(short‐term) and at weeks 16, 20, and 24 (longer‐term) SECONDARY OUTCOME: Biochemical parameters (HbA1c, lipid profile, CBC, LFTs, KFTs)Timepoint: Baseline and month 6 Change in severity of dependency using the Fagerstrom test for nicotine dependence (FTND) ; Timepoint: Baseline, weekly from 1 to 12weeks (short‐term) and at weeks 16, 20, and 24 (longer‐term) Change in tobacco craving (smoking urge) using the withdrawal/craving scale, the Smoking Urges Brief Questionnaire. (QSU‐Brief)Timepoint: Baseline, weekly from 1 to 12weeks(short‐term) and at weeks 16, 20, and 24 Changes in Hospital Anxiety and Depression Scale scoreTimepoint: Baseline, weekly from 1 to 12weeks (short‐term) and at weeks 16, 20, and 24 Changes in withdrawal symptoms and signs, if any, using the NRS scaleTimepoint: Daily for 10 days. (Physically /telephonic follow‐up) Proportion of participants with tobacco abstinence, defined as self‐reported non‐smoking since the last assessment visit (self‐reported) as assessedTimepoint: Baseline, Day 2, weekly from 1 to 12 (short‐term) and at weeks 16, 20, and 24 (longer‐term) using self‐report. To assess the change in plasma/ saliva/ and urine cotinine levelsTimepoint: Baseline, month 3, and month 6. INCLUSION CRITERIA: 1. Adults aged 18 65 years of both genders. 2. Daily tobacco users willing to attempt cessation. 3. Daily tobacco users currently smoking 10 or more cigarettes per day or consuming smokeless tobacco such as ghuta, Khaini (at least 10 units or more a day) 4. Willing to participate in Rajyoga meditation sessions. 5. Participants with controlled Diabetes and Controlled Hypertension. 6. Willing to give voluntarily written Informed consent.